Actively Recruiting
TumorGlow Intraoperative Molecular Imaging (IMI)
Led by University of Pennsylvania · Updated on 2026-03-09
500
Participants Needed
1
Research Sites
126 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a Phase 1/2 study in patients presenting with any solid tumor and/or diseased tissue even benign nodules presumed to be resectable and at risk for recurrence on pre-operative assessment who are considered to be good surgical candidates to evaluate the safety and efficacy of the image-guided surgery using indocyanine green for intramolecular imaging of solid tumors.
CONDITIONS
Official Title
TumorGlow Intraoperative Molecular Imaging (IMI)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults 18 years of age or older
- Patients with any solid tumor or diseased tissue, including benign nodules, presumed resectable and at risk for recurrence
- Good surgical candidate as determined by the treating physician or multidisciplinary team
- Able to give informed consent
You will not qualify if you...
- Unable to participate in the informed consent process
- Vulnerable populations including pregnant women, prisoners, and children
- History of uncontrolled hypertension or emergency admission for hypertensive crisis
- Self-reported history of iodide allergies
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104
Actively Recruiting
Research Team
A
Azra Din
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here